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Estimating the incidence and the prevalence of psychotic disorders in the province of 
Quebec has been the object of some interest in recent years as a contribution to the 
epidemiological study of the causes of psychotic disorders being carried out primarily in 
UK and Scandinavia. A number of studies have used administrative data from the Régie de 
l’assurance maladie du Québec (RAMQ) that includes nearly all Quebec citizens to obtain 
geographical and temporal prevalence estimates for the illness. However, there has been 
no investigation of the validity of RAMQ diagnoses for psychotic disorders, and without 
a measure of the sensitivity and the specificity of these diagnoses, it is impossible to be 
confident in the accuracy of the estimates obtained. This paper proposes the use of latent 
class analysis to ascertain the validity of a diagnosis of schizophrenia using RAMQ data.
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Introduction
The link between urban living and psychosis has intrigued researchers since the first description 
of the phenomenon in the seminal studies of Faris and Dunham (1, 2) who found higher rates of 
schizophrenia in Chicago neighborhoods characterized by social isolation and disorganization but 
found no parallel difference for bipolar disorder. Since then, a large number of studies have confirmed 
the relationship between city size and schizophrenia as well as a dose–response association (3–6). The 
correlation remains unchanged whether schizophrenia or psychosis, more broadly, is under considera-
tion (6) and holds true both of the relation between psychosis and absolute city size and population 
density. A meta-analysis by Vassos et al. (6) found that relative to the most rural environment, the 
most urban environment is associated with a 2.37-fold risk of schizophrenia (6).
The majority of studies on the urban effect in schizophrenia have been carried out either in 
large metropolises [particularly London (7), with a population of approximately 8.3 million] or the 
relatively small cities of Scandinavia [especially Copenhagen (8), with a population of approximately 
0.6 million]. Little data exist for urban areas intermediate between these. Our purpose here is 
to outline an approach to studying the prevalence of schizophrenia in the Canadian province of 
Quebec with a particular focus on Montreal. An island city with a population of approximately 
1.89 million (9), Montreal is the largest urban region in Quebec, and a French-speaking enclave in 
North America. In addition to its linguistic diversity, Montreal is also a hub for new immigrants 
to Canada and is thus home to a great variety of cultural and ethnic communities. In 2005, in 
the neighborhood of Côte-des-Neiges, one of the most diverse neighborhoods in Canada, some 
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51% of the 100,000 residents were immigrants (10). Unlike some 
more homogeneous North American cities, Montreal is also 
marked by significant social differences across neighborhoods. 
For these reasons, Montreal presents a particularly interesting 
laboratory in which to explore the social effects of urban living on 
schizophrenia. Interestingly, a study conducted in 2013 showed 
that the incidence rate of the disorder was higher in the Island 
of Montreal than in the next-largest urban area in the province, 
Quebec City (11).
The first part of this paper examines how administrative 
databases have been used in Quebec and other provinces of 
Canada to study the prevalence and incidence of psychotic 
disorders. (Prevalence measures the number of cases of a disease 
at a single moment in time, while incidence measures the risk 
for a single individual of developing a disease during a given 
period.) We pay close attention to the question of the validity of 
the diagnosis recorded in the database. Although this question 
has been addressed in the context of a number of diseases and 
conditions, it has not been examined in the case of schizophrenia 
or other psychotic disorders. We then describe an ascertainment 
methodology based on Bayesian latent class modeling that makes it 
possible to estimate the validity of the diagnosis of schizophrenia. 
Finally, using previously published data, we show that the new 
method delivers results that are significantly different from those 
currently available.
the Urban effect
The causes of the urban effect in schizophrenia are currently 
unknown. However, it represents an important problem for the 
theory of schizophrenia, because there is little evidence that urban 
living contributes to an increased risk of schizophrenia by means 
of straightforward biological mechanisms. For example, the urban 
effect does not seem to be a function of increased viral transmis-
sion, the increased availability of drugs of abuse, or the tendency of 
immigrants – also at increased risk of schizophrenia – to move to 
cities. Further, the evidence is incompatible with the hypothesis that 
people with schizophrenia merely tend to drift to urban areas – the 
so-called “social drift” hypothesis [(4, 12–15); see also Ref. (16)].
In contrast, there is evidence that the risk of urban living on 
schizophrenia is raised as a function of social processes. Some of 
the most compelling evidence for this view comes from the dis-
covery of differential rates of schizophrenia across neighborhoods 
of London. It is assumed that if the urban effect in schizophrenia 
involves physical processes, one would expect the same prevalence 
across the city. Neighborhood differences, however, are social 
differences (7, 17, 18).
The best known theoretical proposal concerning how social 
factors might contribute to an increased risk for schizophrenia is 
the “social defeat” hypothesis of Selten and Cantor-Graae [(19); 
see also Ref. (20)] according to which experiences of subordination 
or humiliation have effects on the hypothalamic–pituitary–adrenal 
axis, which alter dopamine function and thereby alter the risk 
of psychosis (21). Since experiences of subordination are more 
common among individuals in ethnic or other minority groups, a 
consequence of this view is that discrimination may be an indirect 
cause of schizophrenia. This hypothesis is supported by the finding 
that the risk of developing psychotic symptoms increases with 
perceived discrimination (22).
A second possibility – not incompatible with the first – is that 
“social fragmentation” may be the most important factor explain-
ing the higher rate of schizophrenia in urban settings (23). This 
fragmentation could manifest at the level of family structure (12, 
24) or may be a property of whole neighborhoods (25). Indeed, 
a study by Kirkbride and colleagues measured voter turnout in 
council elections as a marker of social cohesion (i.e., low social 
fragmentation) and found lower rates of schizophrenia in less 
fragmented neighborhoods (7).
epidemiological studies of Psychotic 
disorders in the Province of Quebec
Because epidemiological studies of disease prevalence can be 
prohibitively expensive and labor intensive, estimating prevalence 
usually depends on the availability of administrative data – that 
is, data collected (typically by the government) for administrative 
purposes (26). In Quebec, the medical system is almost exclu-
sively public, and diagnostic and treatment data are collected for 
insurance purposes by the Régie de l’assurance maladie du Québec 
(Quebec Office of Health Insurance; RAMQ). The RAMQ was 
established in 1969 to provide Quebec residents with universal 
health insurance covering physician as well as hospital services, in 
addition to managing health administration databases. The data are 
collected routinely in order to compensate physicians and hospitals 
as well as to monitor or manage programs. Since medical data are 
linked to precise geographic information available for research 
purposes, prevalence rates for neighborhoods can be inferred. But 
because RAMQ data are not collected for research purposes, but 
rather for the purpose of physician reimbursement, the primary 
challenge to using it is establishing its reliability (27). There is 
considerable anecdotal evidence of inaccuracy in the diagnosis 
indicated on administrative forms, which may be attributable 
to the physician, or to the many individuals involved with the 
recording of the information (28). In addition, in the absence of any 
biomarkers, different clinicians may disagree on a given diagnosis, 
and because professionals do no get paid by diagnosis, the incentive 
to get it right is not as great as it might otherwise be. Moreover, 
little research has been carried out into the validity of psychiatric 
diagnosis included in the RAMQ database (29, 30).
Byrne et  al. (31) address the issue of validity in psychiatric 
studies based on administrative registers in a systematic review of 
14 papers, most of which are concerned with schizophrenia. The 
authors conclude that there is a general lack of clarity about what 
counts as a valid diagnosis and how to measure it (31). Indeed, 
Rawson et al. (28) point out that even though the potential for 
biases are frequently acknowledged, administrative data have been 
uncritically accepted as valid and reliable (28). There is, therefore, 
a need to properly evaluate the results of epidemiological studies 
of schizophrenia using administrative data, not least because the 
results are used by health planners and policy makers to develop 
and implement intervention services (11). More importantly, for 
present purposes, a validation of RAMQ data on schizophrenia is 
necessary in order to carry out the finer-grained analysis required 
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to better understand the social factors at play in the genesis of the 
illness. A more precise method for assessing the prevalence of 
schizophrenia in Quebec would make it possible to study subtle 
variations across and within neighborhoods.
The use of administrative data for epidemiological studies is not 
new; it has been used in Quebec (32) and elsewhere (33) to study 
various diseases including schizophrenia (34). RAMQ data, in 
particular, have been used to estimate the prevalence and incidence 
of various diseases (35–37), as well as different forms of psychotic 
disorder in Quebec (11, 29, 30). The main advantages of using 
RAMQ databases are ease of access and low cost (29). Because 
continuous data are available from 1980s to 1990s (depending 
on the particular dataset) (38), longitudinal investigations are 
possible (29). In addition, data are exhaustive since there are 
no privately funded facilities where patients with schizophrenia 
receive treatment (30).
The RAMQ collects information through various sources (38). 
The “Quebec physician claims” database includes fee-for-service 
physician claims for services occurring in a hospital, such as a 
physician visit or consultation, a surgery, or post-operative care. 
It also includes claims for ambulatory (out-of-hospital) care – for 
example, physician visits in a doctor’s office, an emergency room 
visit, or a minor surgery (39). The physician claim includes a 
diagnosis based on the international classification of diseases 
(ICD), the physician specialty, as well as codes indicating medical 
procedures to be carried out based on the Canadian Classification 
of Diagnostic, Therapeutic, and Surgical Procedures, and the loca-
tion of the procedure. The MED-ECHO data source provides the 
discharge summary following any hospitalizations, such as acute 
care, long-term care, and day surgery, and includes diagnosis based 
on the same classification. A primary diagnosis is provided, as 
well as up to 19 secondary diagnoses. Records are also available 
from frontline public health and social services clinics (Centres 
local de services communautaires; CLSCs) as well as residential 
and long-term care facilities (Centres d’hébergement et de soins de 
longue durée; CHSLDs). Sociodemographic information, such as 
age and sex, the location of the residence of the patient based on a 
six-digit postal code, and a unique personal identification number 
are included. Indicators of social and material deprivation are also 
collected (30). Finally, the RAMQ collects data on drugs prescribed 
as well as their dosages (30).
Three epidemiologic studies have been carried out on psychotic 
disorders using RAMQ data. In the first, Anderson et  al. (30) 
estimated the incidence of first-episode psychosis in Montreal 
(30). To be included in the study, patients had to be between 
14 and 25 years old and have resided in Montreal between 2004 
and 2006. Cases were associated with one of the following: (a) 
a physician claim for schizophrenia-spectrum psychosis (SSP), 
which includes schizophrenia, schizophreniform disorder, 
schizoaffective disorder, or delusional disorder, with a psychiatric 
procedure; (b) a local community clinic visit for schizophrenia 
or other psychotic disorder and a procedure code for a mental 
health or emergency visit; or (c) a hospitalization with a primary 
or secondary discharge diagnosis of SSP. Patients with a previous 
medical claim for a psychotic disorder or a previous prescription 
of antipsychotic medication were excluded. The authors identified 
456 patients diagnosed with a SSP, and after adjusting for age and 
sex, they estimated that there were 82.9 cases per 100,000 men per 
year, and 32.2 cases per 100,000 women per year. The diagnosis of 
psychotic disorder was made by a psychiatrist in 69% of cases, and 
in 60% of cases the diagnosis was established in the emergency 
room. Anderson et al. (30) also made use of two indices of social 
and material deprivation as an estimate of socioeconomic disparity, 
which have a high level of geographic resolution (40). The authors 
found that the most deprived areas had a higher incidence of SSP.
The objective of the second study of Vanasse et al. (29) was 
to develop a method to estimate both the prevalence and the 
incidence of the diagnosis of schizophrenia by comparing four 
different case selection algorithms (29). Data were collected in 
Quebec’s physician claims as well as in the hospital discharge 
(MED-ECHO) databases. Every adult given a hospital discharge 
with a diagnosis of schizophrenia or associated with a physician 
claim for it from January 1996 to December 2006 was included 
in the analysis. The algorithms used either physician claims 
alone, or a mix of hospital and physician claims. Algorithm 1 is 
based only on hospitalization with a diagnosis of schizophrenia; 
algorithm 2 on either a hospitalization or an emergency room 
visit with a diagnosis of schizophrenia; algorithm 3 takes into 
account either a hospitalization or a visit to a psychiatrist with a 
recorded diagnosis of schizophrenia; and algorithm 4 is based on 
either a hospitalization or a visit to any physician with a recorded 
diagnosis of schizophrenia. The lifetime treatment prevalence of 
schizophrenia (i.e., the percentage of the population who received 
a diagnosis of schizophrenia during 11 years period of the study) 
was estimated to vary from 0.59 to 1.46% and the incidence was 
estimated to be between 42 and 94 cases per 100,000 individu-
als in the year 2006. In a subsequent paper, this research team 
studied the incidence of schizophrenia between 2004 and 2007 
(11). Patients included in the study were 18 years of age or older 
and had received a diagnosis of schizophrenia recorded in one of 
the same two databases used in the first study. The incidence rate 
of cases was found to be higher in the urban area Montreal than 
in other regions (11).
Other estimates of the prevalence of schizophrenia have been 
conducted in Canada using administrative databases. A Canadian 
study used administrative data in British Columbia and estimated 
the prevalence of schizophrenic disorders to vary from 0.42 to 0.45 
cases per 100,000 (34). A report from the Agence de la santé et des 
services sociaux de Montréal (Montreal Health and Social Services 
Agency), which comprises 18 regional authorities supporting the 
Ministry of Health and Social Services (41), estimated the 1-year 
prevalence of schizophrenia in Montreal to be 0.57% (42).
A Limitation of epidemiological studies of 
Psychosis Based on Administrative 
databases
An important limitation of these studies is their presumption 
that the diagnosis of schizophrenia as found in the administrative 
database is valid. That is, all of the studies assume that the method 
of ascertainment used is both 100% specific and 100% sensitive. In 
the absence of a proper estimation of the validity of the diagnosis 
under investigation, however, relying on these results requires a 
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leap of faith. The problem is particularly acute given the fact that 
the primary purpose of RAMQ data is physician reimbursement. 
As we note above, a systematic review of psychiatric studies based 
on administrative data finds that there is considerable lack of clarity 
about how to validate diagnoses (31).
There is some circumstantial evidence for the accuracy of 
psychiatric diagnoses as found in administrative databases. A 2009 
study, for example, showed that administrative data in Canada 
could be reliably used for mental disorder surveillance (43) (i.e., 
the continuous collection of data to plan and implement mental 
health policy) (44). Moreover, an estimate of the prevalence of 
bipolar disorder based on administrative data in Canada was found 
to be comparable to the results of a health survey (45). However, 
mental health surveys may underestimate the real burden of 
mental disorders due to fear of stigmatization or selection bias 
(29), and, more generally, because of inaccuracies in self-reports 
of mental illness.
A study of the validity of a diagnosis for schizophrenia and 
depressive disorder from a Canadian administrative database in 
Saskatchewan was conducted by Rawson et al. (28). In particular, 
they compared diagnoses from three sources of data and reported 
the percentage of agreement between each pair. The concordance 
was found to be 94% between computerized hospital data and 
medical charts for schizophrenia. Without an attempt to estimate 
specificity by including a random sample of non-schizophrenic 
subjects, however, the validity analysis remains incomplete. 
Interestingly, a study designed to validate the diagnosis of schizo-
phrenia as found in the Swedish National Inpatient Register (46) 
found that the proportion of “true” cases was high and the number 
of false positives was no different in the hospitals in larger cities 
than those in smaller towns (46).
In contrast, however, there is a wealth of evidence from 
epidemiological research into other diseases to suggest that the 
assumption of perfect sensitivity and specificity of the diagnostic 
codes in a database does not hold (47). A satisfactory validation of 
the diagnosis of schizophrenia in the RAMQ database is required, 
therefore, before one can be confident of using this data for epi-
demiological purposes.
A Bayesian Latent Class Model for 
Prevalence estimation
To produce an adjusted prevalence estimate, one needs a good 
estimate of the sensitivity and specificity of the diagnoses in the 
database. For example, if P is the observed proportion of positive 
diagnoses in the database, π is the true prevalence, and S and C 
are the sensitivity and specificity, respectively, then we can reason 
as follows: positive results can arise either by the test correctly 
detecting a truly positive case, or by the test falsely detecting a truly 
negative case. The first case will arise with probability π*S, since 
the case is positive with probability given by the prevalence π, and 
the test will correctly detect a true positive with probability given 
by the sensitivity, S. The second case will arise with probability 
(1−π)*(1−C), since the case is negative with probability given by 
one minus the prevalence, or (1−π), and the test will incorrectly 
label a true negative as positive with probability given by one minus 
the specificity, or (1−C). Therefore, the total probability of the test 
coming up positive is given by
 P = + − −pi pi* ( )( ),S C1 1  
and solving this algebraic equation for the prevalence π gives
 pi = + − + −( ) / ( ).P C S C1 1  
Note that if S = C = 1 (sensitivity = specificity = 100%) then 
we are back to the standard assumption of perfect accuracy, and 
the estimate of the prevalence reduces to the rate of positive tests, 
P. Otherwise, the prevalence will be different from the observed 
“prevalence” as given by the number of positive tests, and in many 
cases the true prevalence can be very far from P.
There are at least two ways to establish the sensitivity and speci-
ficity of diagnostic codes or other clues found in administrative 
databases for any disease or condition. The most direct method 
is to gather a large enough sample of known cases and controls, 
and check for the presence or absence of the diagnostic code in 
the database. The rate of positive diagnoses found in the database 
among truly positive subjects is an estimate of the sensitivity, 
and the rate of negative diagnoses found among truly negative 
subjects is an estimate of the specificity. Such studies can be time 
consuming, but are feasible to carry out provided there is a source 
of known cases and controls.
Alternatively, one can use latent class models (48, 49), which 
can be divided into two types, identifiable and non-identifiable. 
Roughly speaking, identifiable latent class models are those 
where all unknown parameters can be estimated without the 
use of information external to the data set. One example would 
be when three tests or “clues” in the database are available. For 
example, in addition to the main diagnostic code, one can look for 
the presence or absence of medications and medical procedures 
that would be particular to the disease or condition under study. 
If three independent clues can be found, then there are seven 
parameters (sensitivity and specificity for each of the three clues 
along with the prevalence) to estimate from the 2 × 2 × 2 table 
of data, which provides seven degrees of freedom. Thus, one can 
use standard frequentist latent class models (50) or a Bayesian 
approach with minimum information priors (49) to estimate 
all parameters simultaneously. The Bayesian approach uses the 
same model (likelihood function) as the frequentist approach, the 
only difference being the prior information input by the Bayesian 
method. However, if minimum prior information is input (through 
what is often loosely termed as non-informative priors) then the 
two methods will provide numerically similar inferences.
Non-identifiable latent class models are used when there are 
more parameters to estimate than there are degrees of freedom. 
Such a model can be used, for example, when only the main diag-
nostic code is used to ascertain case status. In that situation, there 
will be three parameters to estimate (sensitivity and specificity 
of the diagnostic code, and the prevalence), but only one degree 
of freedom in the yes/no diagnostic data. In this case, one must 
employ information from outside the data set in order to provide 
reasonable inferences, with the information ideally coming from 
a prior study that outlined above to estimate the sensitivity and 
specificity of the diagnostic code, following which one can estimate 
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the prevalence. Here, only Bayesian analysis can provide reason-
able inferences (48).
Of course, it will not be possible to assess the validity of every 
diagnosis of psychotic disorders; it will be necessary to choose a 
sub-population. For this population, we would need to compare 
the diagnosis as found in the database to another measure, such 
as the hospital chart, which would be used as a proxy measure for 
the true presence of the illness. Hospital charts might sometimes 
be wrong due to misdiagnosis, and some individuals might never 
be treated in the health care system and so fail to be represented 
as having schizophrenia in the data set. In this case, we return to 
a non-identifiable model but with one of the “tests” presumably 
providing high enough sensitivity and specificity to lead to accurate 
prevalence estimates, using the prevalence conversion formula 
given above.
Our study will proceed in three stages. First, we will estimate 
the sensitivity and specificity of RAMQ-based diagnoses of 
schizophrenia by collecting a sample of known cases with and 
without schizophrenia, and comparing RAMQ diagnoses to 
hospital charts. These cases will come from the Psychotic Disorder 
Programs offering services to patients aged from 18 to 65 suffering 
schizophrenia and other forms of psychosis in the catchment area 
covered by the Douglas Mental Health University Institute (51) in 
Montreal, while controls will be individuals randomly selected in 
the same area. The Douglas Institute represents the highest level 
of care for schizophrenia in Montreal and will thus provide a best 
case scenario for estimating sensitivity.
In the second stage, we will use RAMQ data to estimate the 
prevalence of schizophrenia, adjusting by the sensitivity and 
specificity estimates obtained from stage 1. Note that the sensitivity 
and specificity estimates here will be entered as prior densities, and 
not point estimates, since even with the most carefully designed 
first step, these quantities will not be known exactly. The prob-
ability densities will thus reflect the uncertainty associated with 
not knowing the exact values for these quantities.
In the third stage, we will re-estimate the prevalence of 
schizophrenia using three tests from the RAMQ database. One 
test will be the imperfect diagnosis as recorded in the database. The 
second test will be the prescription of antipsychotic medications 
at a therapeutic dosage for schizophrenia, and the third will be 
hospitalizations or a psychiatric procedure code. With these tests, 
we can estimate sensitivity and specificity by means of latent class 
modeling. We will thus be able to check the robustness of the 
prevalence estimate from step 2, as well as re-estimate and compare 
with the estimates of the sensitivity and specificity from step 1.
Finally, since we are interested in comparing the rates of schizo-
phrenia in different districts of Montreal, we will repeat the above 
steps for each sub-area of interest. This can be done by running 
separate latent class models within each of the areas of interest, and 
also via one larger hierarchical Bayesian model that incorporates 
a latent class component. Separate models have the advantage of 
independence of estimates, but may suffer from small sample sizes. 
On the other hand, hierarchical models pool all data together, and 
hence, use a larger sample size, but represent a trade-off between 
bias and precision. We will run both methods and compare the 
robustness of the results across methods.
Since the publication of the seminal paper on the Bayesian 
estimation of disease prevalence (51), this methodology has been 
used in a wide array of epidemiological studies and its validity has 
been well recognized. However, to our knowledge, it is the first 
time that it will be used for the estimation of the prevalence of a 
psychiatric disorder using an administrative database.
Application of the Bayesian Latent Class 
Model to Previous studies
As an illustration of an application of our method consider the 
result of Vanasse et  al. (29) discussed above. They estimated a 
prevalence of schizophrenia in Quebec of 0.59–1.46% using 
algorithms assuming 100% sensitivity and specificity in order 
to derive their estimates. The sensitivities and specificities from 
each algorithm are unknown, but are surely <100%. Let’s sup-
pose we assume imperfect – but still excellent – sensitivity and 
specificity values of 99.5, and 1% prevalence, which corresponds 
roughly to the mid-point of their range. Using these values, we 
derive an adjusted prevalence of 0.5%, which is lower than even 
their lower limit. Clearly, small deviations for the assumption of 
perfect sensitivity and specificity may lead to substantial errors in 
prevalence estimation.
A further demonstration of the power of the technique when 
applied to RAMQ data is contained in Ladouceur et al. (49). In 
that paper, an unadjusted osteoarthristis prevalence estimate of 
10.0% was adjusted to 14.8%, an increase of almost 50%. Thus, 
unadjusted estimates from administrative databases must be 
treated with caution.
Conclusion
The Quebec health care system was not created for the purpose 
of conducting epidemiological studies, but the administrative 
data available through RAMQ provide a valuable opportunity to 
conduct epidemiological research. Since there are good reasons 
to believe that schizophrenia is linked to the social world, the use 
of administrative data makes it possible to get access to a large 
database of information that can be linked to social variables 
in a much less labor-intensive fashion than would otherwise be 
necessary. This effort will only bear fruit, however, if we can have 
confidence in the estimates it delivers; the Bayesian approach 
sketched above will go some way to providing that confidence. A 
more precise method for assessing the prevalence of schizophrenia 
in Quebec would make it possible to carry out the finer-grained 
analysis required to better understand the social factors at play 
in the genesis of the illness – in particular, the social variations 
that correlate with illness across and within neighborhoods. With 
this data in hand, the picture of schizophrenia in Quebec will fill 
a significant gap in the epidemiological study of schizophrenia.
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